Long non-coding RNAs and cell death following ischemic stroke

Metab Brain Dis. 2019 Oct;34(5):1243-1251. doi: 10.1007/s11011-019-00423-2. Epub 2019 May 4.

Abstract

Stroke is a major cause of morbidity and mortality worldwide, and extensive efforts have focused on the improvement of therapeutic strategies to reduce cell death following ischemic stroke. Uncovering the cellular and molecular pathophysiological processes in ischemic stroke have been a top priority. Long noncoding RNAs (lncRNAs) are endogenous molecules that play key roles in the pathophysiology of cerebral ischemia, and involved in the neuronal cell death during ischemic stroke. In recent years, a bulk of aberrantly expressed lncRNAs have been screened out in ischemic stroke insulted animals. LncRNAs along with their targets could affect the genetic machinery at molecular levels, and exploring their functions and mechanisms may be a promising option for ischemic stroke treatment. In this review, we summarize the current knowledge for lncRNAs in ischemic stroke, focusing on the role of specific lncRNAs that may underlie cell death to find possible therapeutic targets.

Keywords: Cell death; Ischemic stroke; Long non-coding RNA.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / metabolism*
  • Brain / pathology
  • Brain Ischemia / genetics
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • Cell Death / physiology*
  • Humans
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • Stroke / genetics
  • Stroke / metabolism*
  • Stroke / pathology

Substances

  • RNA, Long Noncoding